To investigate whether radiomics based on contrast-enhanced MRI can predict pathological complete response(pCR) and disease-free survival(DFS) of locally advanced TNBC undergoing neoadjuvant chemotherapy(NAC).
This abstract and the presentation materials are available to members only; a login is required.